Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 48
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 41
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 41
  • 0 comments

FDA approve GOLIMUMAB

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 42
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 47
  • 0 comments

FDA approve DEXMEDETOMIDINE HYDROCHLORIDE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 46
  • 0 comments

FDA approve CARBIDOPA; ENTACAPONE; LEVODOPA

Comment Full text

MSN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 43
  • 0 comments

FDA approve RUFINAMIDE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 50
  • 0 comments

FDA approve DIVALPROEX SODIUM

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 47
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 52
  • 0 comments

FDA approve RANOLAZINE

Comment Full text
  • Previous
  • 151
  • 152
  • 153
  • 154
  • 155
  • Next

Search

News categories

  • Technical Exchange News(10597)
  • Event(2007)
  • SEC News(184706)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122346)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin